Variant NM_000492.4:c.3909C>G
Name | NM_000492.4:c.3909C>G |
Protein name | NP_000483.3:p.(Asn1303Lys) |
Genomic name (hg19) | chr7:g.117292931C>G UCSC |
#Exon/intron | exon 24 |
Legacy Name | N1303K |
Class | disease-causing |
Subclass | CF-causing |
WT sequence | TTTTTTCTGGAACATTTAGAAAAAA C TTGGATCCCTATGAACAGTGGAGTG |
Mutant sequence | TTTTTTCTGGAACATTTAGAAAAAA G TTGGATCCCTATGAACAGTGGAGTG |
dbSNP rs80034486 |
3 individuals carrying this variant are reported in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 181 |
---|---|
Asymptomatic compound heterozygote | 6 |
CF | 123 |
CFTR-RD | 37
|
Fetal bowel anomalies | 5 |
Pending (NBS) | 10 |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
CF | 5016 | heterozygote | varying clinical consequence- Undef |
CF | 2754 | heterozygote | CF-causing - Trans |
CF | 2739 | heterozygote | CF-causing - Trans |
CF | 2675 | heterozygote | VUS1- Undef CF-causing- Undef |
CF | 2666 | heterozygote | CF-causing- Undef |
CF | 2639 | heterozygote | CF-causing- Undef |
CF | 4925 | heterozygote | CF-causing - Trans |
CF | 2760 | heterozygote | varying clinical consequence - Trans |
CF | 2775 | heterozygote | CF-causing- Undef |
CF | 3077 | heterozygote | CF-causing- Undef |
CF | 4633 | heterozygote | CF-causing- Undef |
CF | 2957 | heterozygote | CF-causing- Undef |
CF | 2921 | heterozygote | CF-causing - Trans |
CF | 2898 | heterozygote | CF-causing - Trans VUS3- Undef |
CF | 2818 | heterozygote | CF-causing - Trans |
CF | 2266 | heterozygote | CF-causing- Undef |
CF | 1999 | heterozygote | VUS1- Undef CF-causing- Undef |
CF | 1995 | heterozygote | CF-causing- Undef |
CF | 1934 | heterozygote | CF-causing- Undef |
CF | 2385 | heterozygote | CF-causing- Undef |
CF | 2480 | heterozygote | CF-causing- Undef |
CF | 2560 | heterozygote | CF-causing- Undef |
CF | 2550 | heterozygote | CF-causing- Undef |
CF | 2518 | heterozygote | CF-causing- Undef |
CF | 2515 | heterozygote | CF-causing- Undef |
CF | 2482 | heterozygote | CF-causing- Undef |
CF | 4181 | heterozygote | CF-causing - Trans |
CF | 4172 | heterozygote | CF-causing- Undef |
CF | 4114 | heterozygote | CF-causing - Trans |
CF | 4101 | heterozygote | CF-causing- Undef |
CF | 3921 | heterozygote | CF-causing- Undef |
CF | 4329 | heterozygote | CF-causing - Trans |
CF | 6174 | heterozygote | CF-causing - Trans |
CF | 6087 | heterozygote | CF-causing- Undef |
CF | 4476 | heterozygote | CF-causing - Trans |
CF | 4443 | heterozygote | CF-causing - Trans |
CF | 4390 | heterozygote | varying clinical consequence - Trans |
CF | 3862 | heterozygote | varying clinical consequence- Undef |
CF | 3828 | heterozygote | CF-causing- Undef |
CF | 3308 | heterozygote | CF-causing - Trans |
CF | 3302 | heterozygote | CF-causing - Trans |
CF | 3282 | heterozygote | CF-causing- Undef |
CF | 3260 | heterozygote | CF-causing - Trans |
CF | 3256 | heterozygote | CF-causing - Trans |
CF | 3218 | heterozygote | CF-causing- Undef |
CF | 3179 | heterozygote | CF-causing - Trans |
CF | 3385 | heterozygote | CF-causing - Trans |
CF | 3635 | heterozygote | CF-causing - Trans |
CF | 3546 | heterozygote | CF-causing - Trans |
CF | 3461 | heterozygote | CF-causing - Trans |
CF | 3441 | heterozygote | CF-causing - Trans |
CF | 3435 | heterozygote | CF-causing- Undef |
CF | 3122 | heterozygote | CF-causing - Trans |
CF | 1918 | heterozygote | CF-causing- Undef |
CF | 1008 | heterozygote | CF-causing - Trans |
CF | 586 | heterozygote | CF-causing- Undef |
CF | 582 | heterozygote | varying clinical consequence- Undef |
CF | 383 | heterozygote | varying clinical consequence - Trans CF-causing - Trans |
CF | 657 | heterozygote | CF-causing - Trans |
CF | 715 | heterozygote | CF-causing - Trans |
CF | 723 | heterozygote | CF-causing - Trans |
CF | 872 | heterozygote | CF-causing - Trans |
CF | 869 | heterozygote | CF-causing - Trans |
CF | 843 | heterozygote | CF-causing - Trans |
CF | 808 | heterozygote | varying clinical consequence - Trans |
CF | 344 | heterozygote | CF-causing - Trans |
CF | 343 | heterozygote | CF-causing - Trans |
CF | 906 | heterozygote | CF-causing - Trans |
CF | 64 | heterozygote | CF-causing- Undef |
CF | 46 | heterozygote | CF-causing - Trans |
CF | 37 | heterozygote | CF-causing - Trans |
CF | 16 | heterozygote | CF-causing- Undef |
CF | 14 | heterozygote | CF-causing - Trans |
CF | 120 | heterozygote | CF-causing - Trans |
CF | 128 | heterozygote | varying clinical consequence - Trans |
CF | 130 | heterozygote | CF-causing - Trans |
CF | 251 | heterozygote | CF-causing - Trans |
CF | 224 | heterozygote | CF-causing - Trans |
CF | 212 | heterozygote | CF-causing - Trans |
CF | 199 | heterozygote | CF-causing- Undef |
CF | 185 | heterozygote | CF-causing - Trans |
CF | 140 | heterozygote | CF-causing - Trans |
CF | 139 | heterozygote | likely CF - Trans |
CF | 3 | heterozygote | CF-causing - Trans |
CF | 1916 | heterozygote | CF-causing- Undef |
CF | 1782 | heterozygote | CF-causing- Undef |
CF | 1642 | heterozygote | CF-causing- Undef |
CF | 1614 | heterozygote | CF-causing- Undef |
CF | 1612 | heterozygote | CF-causing- Undef |
CF | 5438 | heterozygote | varying clinical consequence - Trans |
CF | 1558 | heterozygote | CF-causing- Undef |
CF | 1519 | heterozygote | CFTR-RD-causing - Trans varying clinical consequence - Trans |
CF | 4990 | heterozygote | CF-causing - Trans |
CF | 1873 | heterozygote | CF-causing- Undef |
CF | 1861 | heterozygote | CF-causing- Undef |
CF | 5110 | heterozygote | CF-causing - Trans |
CF | 1834 | heterozygote | CF-causing- Undef |
CF | 5055 | heterozygote | CF-causing- Undef |
CF | 4992 | heterozygote | CF-causing - Trans |
CF | 4991 | heterozygote | CF-causing - Trans |
CF | 1159 | heterozygote | CF-causing - Trans |
CF | 1131 | heterozygote | CF-causing - Trans |
CF | 1081 | heterozygote | CF-causing - Trans |
CF | 1050 | heterozygote | CF-causing- Undef |
CF | 1014 | heterozygote | CF-causing - Trans |
CF | 5811 | heterozygote | CF-causing- Undef |
CF | 1010 | heterozygote | CF-causing - Trans |
CF | 1165 | heterozygote | CF-causing - Trans |
CF | 1297 | heterozygote | CF-causing- Undef |
CF | 1320 | heterozygote | CF-causing- Undef |
CF | 1235 | heterozygote | CF-causing - Trans |
CF | 1211 | heterozygote | CF-causing- Undef |
CF | 1206 | heterozygote | CF-causing - Trans |
CF | 275 | homozygote | c.3909C>G - p.(Asn1303Lys) - Trans |
CF | 930 | homozygote | c.3909C>G - p.(Asn1303Lys) - Trans |
CF | 1747 | homozygote | c.3909C>G - p.(Asn1303Lys) - Trans |
CF | 2195 | homozygote | c.3909C>G - p.(Asn1303Lys) - Trans |
CF | 269 | homozygote | c.3909C>G - p.(Asn1303Lys) - Trans |
CF | 4512 | homozygote | c.3909C>G - p.(Asn1303Lys) - Trans |
CF | 127 | homozygote | c.3909C>G - p.(Asn1303Lys) - Trans |
CF | 1705 | homozygote | c.3909C>G - p.(Asn1303Lys) - Trans |
CF | 2509 | homozygote | c.3909C>G - p.(Asn1303Lys) - Trans |
CF | 3901 | homozygote | c.3909C>G - p.(Asn1303Lys) - Trans |
Other | 2641 | heterozygote | VUS3- Undef VUS3- Undef |
Other | 2277 | heterozygote | |
Other | 4705 | heterozygote | CF-causing - Trans |
Other | 27 | heterozygote | CFTR-RD-causing - Trans |
Other | 5083 | heterozygote | CFTR-RD-causing- Undef CFTR-RD-causing- Undef |
Bronchiectasis | 4300 | heterozygote | |
Bronchiectasis | 4234 | heterozygote | CFTR-RD-causing - Trans |
Bronchiectasis | 4684 | heterozygote | VUS3- Undef |
Bronchiectasis | 4868 | heterozygote | varying clinical consequence- Undef varying clinical consequence- Undef |
Fetal bowel anomalies | 367 | heterozygote | CF-causing - Trans |
Fetal bowel anomalies | 607 | heterozygote | VUS3 - Trans CF-causing - Trans |
Fetal bowel anomalies | 2535 | heterozygote | |
Fetal bowel anomalies | 3403 | heterozygote | CF-causing - Trans |
Fetal bowel anomalies | 5162 | heterozygote | CF-causing - Trans |
CBAVD | 2689 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 2653 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 4905 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 4897 | heterozygote | VUS3- Undef |
CBAVD | 2348 | heterozygote | varying clinical consequence- Undef |
CBAVD | 4880 | heterozygote | VUS3- Undef |
CBAVD | 2549 | heterozygote | |
CBAVD | 4814 | heterozygote | |
CBAVD | 3274 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 3343 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 500 | heterozygote | non-CF- Undef |
CBAVD | 475 | heterozygote | VUS3- Undef non-CF- Undef |
CBAVD | 407 | heterozygote | CFTR-RD-causing - Trans |
CBAVD | 852 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 841 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 1627 | heterozygote | varying clinical consequence- Undef |
CBAVD | 1833 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 1455 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 1431 | heterozygote | varying clinical consequence- Undef |
CBAVD | 1388 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 5265 | heterozygote | CFTR-RD-causing- Undef |
Pending (NBS) | 5703 | heterozygote | VUS3 - Trans CFTR-RD-causing - Trans CFTR-RD-causing - Trans CFTR-RD-causing - Trans |
Pending (NBS) | 6185 | heterozygote | varying clinical consequence - Trans |
Pending (NBS) | 4243 | heterozygote | likely CFTR-RD - Trans |
Pending (NBS) | 6031 | heterozygote | varying clinical consequence- Undef |
Pending (NBS) | 6084 | heterozygote | CFTR-RD-causing- Undef |
Pending (NBS) | 4606 | heterozygote | CFTR-RD-causing - Trans |
Pending (NBS) | 799 | heterozygote | varying clinical consequence - Trans |
Pending (NBS) | 793 | heterozygote | VUS3 - Trans |
Pending (NBS) | 5853 | heterozygote | CFTR-RD-causing - Trans CFTR-RD-causing - Trans CFTR-RD-causing - Trans |
Pending (NBS) | 1255 | heterozygote | varying clinical consequence - Trans |
Pancreatitis | 3072 | heterozygote | CFTR-RD-causing - Trans |
Pancreatitis | 2286 | heterozygote | |
Pancreatitis | 1960 | heterozygote | varying clinical consequence- Undef |
Pancreatitis | 4891 | heterozygote | CFTR-RD-causing- Undef |
Pancreatitis | 6117 | heterozygote | VUS1 - Trans |
Pancreatitis | 3245 | heterozygote | CFTR-RD-causing - Trans |
Pancreatitis | 4977 | heterozygote | CFTR-RD-causing- Undef |
Asymptomatic compound heterozygote | 2966 | heterozygote | CFTR-RD-causing - Trans |
Asymptomatic compound heterozygote | 2798 | heterozygote | |
Asymptomatic compound heterozygote | 2383 | heterozygote | CFTR-RD-causing- Undef |
Asymptomatic compound heterozygote | 6195 | heterozygote | varying clinical consequence- Undef |
Asymptomatic compound heterozygote | 5161 | heterozygote | CFTR-RD-causing - Trans |
Asymptomatic compound heterozygote | 5606 | heterozygote | VUS3 - Trans non-CF - Trans |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|